Egeler RM - Search Results

1

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.

Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, Arceci RJ, Rollins BJ; Steering Committee of the Nikolas Symposium. Egeler RM, et al. Pediatr Blood Cancer. 2016 Oct;63(10):1704-12. doi: 10.1002/pbc.26104. Epub 2016 Jun 17. Pediatr Blood Cancer. 2016. PMID: 27314817 Review.

2

The coming of age of Langerhans cell histiocytosis.

Allen CE, Beverley PCL, Collin M, Diamond EL, Egeler RM, Ginhoux F, Glass C, Minkov M, Rollins BJ, van Halteren A. Allen CE, et al. Among authors: egeler rm. Nat Immunol. 2020 Jan;21(1):1-7. doi: 10.1038/s41590-019-0558-z. Nat Immunol. 2020. PMID: 31831887 No abstract available.

3

2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.

Weitzman S, Braier J, Donadieu J, Egeler RM, Grois N, Ladisch S, Pötschger U, Webb D, Whitlock J, Arceci RJ. Weitzman S, et al. Among authors: egeler rm. Pediatr Blood Cancer. 2009 Dec 15;53(7):1271-6. doi: 10.1002/pbc.22229. Pediatr Blood Cancer. 2009. PMID: 19731321 Clinical Trial.

4

Somatic activating ARAF mutations in Langerhans cell histiocytosis.

Nelson DS, Quispel W, Badalian-Very G, van Halteren AG, van den Bos C, Bovée JV, Tian SY, Van Hummelen P, Ducar M, MacConaill LE, Egeler RM, Rollins BJ. Nelson DS, et al. Among authors: egeler rm. Blood. 2014 May 15;123(20):3152-5. doi: 10.1182/blood-2013-06-511139. Epub 2014 Mar 20. Blood. 2014. PMID: 24652991 Free article.

5

Biology of Langerhans cells and Langerhans cell histiocytosis.

Bechan GI, Egeler RM, Arceci RJ. Bechan GI, et al. Among authors: egeler rm. Int Rev Cytol. 2006;254:1-43. doi: 10.1016/S0074-7696(06)54001-X. Int Rev Cytol. 2006. PMID: 17147996 Review.

6

Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.

Egeler RM, van Halteren AG, Hogendoorn PC, Laman JD, Leenen PJ. Egeler RM, et al. Immunol Rev. 2010 Mar;234(1):213-32. doi: 10.1111/j.0105-2896.2009.00883.x. Immunol Rev. 2010. PMID: 20193021 Review.

7

MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.

Nelson DS, van Halteren A, Quispel WT, van den Bos C, Bovée JV, Patel B, Badalian-Very G, van Hummelen P, Ducar M, Lin L, MacConaill LE, Egeler RM, Rollins BJ. Nelson DS, et al. Among authors: egeler rm. Genes Chromosomes Cancer. 2015 Jun;54(6):361-8. doi: 10.1002/gcc.22247. Epub 2015 Mar 31. Genes Chromosomes Cancer. 2015. PMID: 25899310

8

Expression of cell cycle-related gene products in Langerhans cell histiocytosis.

Schouten B, Egeler RM, Leenen PJ, Taminiau AH, van den Broek LJ, Hogendoorn PC. Schouten B, et al. Among authors: egeler rm. J Pediatr Hematol Oncol. 2002 Dec;24(9):727-32. doi: 10.1097/00043426-200212000-00009. J Pediatr Hematol Oncol. 2002. PMID: 12468913

9

Langerhans-cell histiocytosis 'insight into DC biology'.

Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM. Laman JD, et al. Among authors: egeler rm. Trends Immunol. 2003 Apr;24(4):190-6. doi: 10.1016/s1471-4906(03)00063-2. Trends Immunol. 2003. PMID: 12697451

10

Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.

Dhall G, Finlay JL, Dunkel IJ, Ettinger LJ, Kellie SJ, Allen JC, Egeler RM, Arceci RJ. Dhall G, et al. Among authors: egeler rm. Pediatr Blood Cancer. 2008 Jan;50(1):72-9. doi: 10.1002/pbc.21225. Pediatr Blood Cancer. 2008. PMID: 17455311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters